Researchers: Merck Vioxx study was for marketing

August 18, 2008 By LINDA A. JOHNSON , AP Business Writer

(AP) -- A 1999 Merck & Co. study of its since-withdrawn painkiller Vioxx, touted to participating doctors and patients as meant to show whether Vioxx caused fewer stomach problems than another drug, was primarily a stealth marketing strategy, researchers report.

Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .

Similar stories from PHYSorg:

Study: Vioxx poses even short-term risks

May 03, 2006 | 4.3 / 5 (3) | 0

Mass. doctor accused of faking pain pill data

Mar 11, 2009 | not rated yet | 0

Drug marketing techniques may be risking patient safety

Dec 03, 2008 | 5 / 5 (1) | 0

FDA probes liver damage with weight loss pill alli

Aug 24, 2009 | not rated yet | 0

Food and drug agency to study greater openness

Jun 02, 2009 | not rated yet | 1

Rate this story - 5 /5 (1 vote)

rank
1
2
3
4
5

view popular

Move the slider to adjust rank threshold, so that you can hide some of the comments.

Display comments: newest first

mvg - Aug 18, 2008
- Rank: not rated yet
So, what what makes these guys(the drug companys) any different from the cigarette companys??

They'll do, and say, anything for money.
- report abuse
- - Current rank
  - 1
  - 2
  - 3
  - 4
  - 5

Other News

Whooping cough vaccine may be losing its punch: study

Medicine & Health / Diseases

48 minutes ago | not rated yet | 0

(PhysOrg.com) -- Vaccination programs against whooping cough may not be fully effective because the bacteria that cause the disease have evolved new strains, a new study has found. A team of Australian scientists has ...

IQ among strongest predictors of cardiovascular disease -- second only to cigarette smoking

Medicine & Health / Health

3 hours ago | not rated yet | 6 |

as reflected by low results on written or oral tests of IQ - have been associated with a raised risk of cardiovascular disease, no study has so far compared the relative strength of this association with other established ...

Communication breakdown: What happens to nerve cells in Parkinson's disease

Medicine & Health / Neuroscience

3 hours ago | not rated yet | 0 |

A new study from The Montreal Neurological Institute and Hospital - The Neuro - at McGill University is the first to discover a molecular link between Parkinson's disease and defects in the ability of nerve cells to communicate. ...

A common cholesterol drug fights cataracts, too

Medicine & Health / Medications

2 hours ago | not rated yet | 1

Statins, a class of drugs used to lower cholesterol levels, have been successfully fighting heart disease for years. A new study from Tel Aviv University has now found that the same drugs cut the risks of cataracts in men ...

Changes proposed in how psychiatrists diagnose

Medicine & Health / Psychology & Psychiatry

2 hours ago | not rated yet | 0

(AP) -- Don't say "mental retardation" - the new term is "intellectual disability." No more diagnoses of Asperger's syndrome - call it a mild version of autism instead. And while "behavioral addictions" will be new to doctors' ...